Journals / Anadolu Kardiyoloji Dergisi / 2006 / Cilt: 6 - Sayı: 1

Impact of psychological factors on development and course of coronary heart disease: Should be negative psychological factors be altered?

Psikolojik faktörlerin koroner kalp hastalığına etkisi: Olumsuz psikolojik faktörlere müdahale edilmeli mi?

Pages
55–59
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Complementary to the traditional treatment, this new treatment strategy could be a different perspective and a nice promise for CHD patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Psychological factors effect the development and course of coronary heart disease (CHD).
📊
Key Findings & Data:Hypothalamic-pituitary-adrenal dysregulation, reduced heart rate variability, diminished baroreflex sensitivity, impaired immune function and altered platelet function are proposed as significant psychophysiologic mechanisms to explain this association.
💡
Conclusion & Impact:Complementary to the traditional treatment, this new treatment strategy could be a different perspective and a nice promise for CHD patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Psychological factors effect the development and course of coronary heart disease (CHD). Hypothalamic-pituitary-adrenal dysregulation, reduced heart rate variability, diminished baroreflex sensitivity, impaired immune function and altered platelet function are proposed as significant psychophysiologic mechanisms to explain this association. Because psychological factors may influence several different stages of long atherosclerosis period, interventional studies aiming to alter negative psychological factors by behavioral and medical ways, expecting to prevent or improve CHD, have been discussed. Complementary to the traditional treatment, this new treatment strategy could be a different perspective and a nice promise for CHD patients.

Özet

Psikolojik faktörler koroner kalp hastalığı (KKH) gelişim ve seyrini etkilemektedir. Bu ilişkiden sorumlu önemli psikofizyolojik mekanizmalar arasında hipotalamik-pituiter-adrenal aksında uyumsuzluk, otonom sinir sistemi fonksiyon bozukluğu, immün fonksiyonunda bozulma ve trombosit fonksiyonunda değişmeler sayılabilir. Bu derlemede psikolojik faktörlerin uzun ateroskleroz gelişim sürecine bir çok noktadan katılma olasılıkları bulunduğundan KKH'yi önlemek ve KKH olanlarda da hastalığın seyrini iyileştirmek için olumsuz psikolojik faktörleri değiştirmenin önemi tartışılmaktadır. Bu yeni tedavi stratejisi KKH hastaları için geleneksel tedaviyi tamamlayan farklı bir yaklaşım ve hoş bir umut olabilir.

🔖

Cite This Article

VURAL, M., BAŞAR, E. (2022). Impact of psychological factors on development and course of coronary heart disease: Should be negative psychological factors be altered?. Anadolu Kardiyoloji Dergisi, Cilt: 6 - Sayı: 1, 55–59. https://ajindex.com/articles/437282

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000; 160: 1261-8
  2. Ariyo AA, Haan M Tangen CM, Rutledge JC, Cushman M, Dobs A, et al. Depressive symptoms and risk of coronary heart disease and mortality at elderly Americans. Circulation 2000;102:1773-9
  3. Smith TW, Ruiz JM. Psychological influences on the development and course of coronary heart disease: Current status and implications for research and practice. J Consult Clin Psychol 2002; 70: 548-68
  4. Onat A, Keleş İ, Çetinkaya A, Başar Ö, Yıldırım B, Erer B, et al. On yıllık TEKHARF Çalışması verilerine göre Türk erişkinlerinde koroner kökenli ölüm ve olayların prevalansı yüksek. Türk Kardiyol Dern Arş 2001; 29: 8-19
  5. Kuey L, Gulec C. Depression in Turkey in the 1980s: epidemiological and clinical approaches. Clin Neuropharmacol 1989; 12 (Suppl 2): 1-12
  6. Tekbas OF, Ceylan S, Hamzaoglu O, Hasde M. An investigation of the prevalence of depressive symptoms in newly recruited young adult men in Turkey. Psychiatry Res 2003; 119: 155-62
  7. Robins LN, Reiger DA. Psychiatric disorders in America. New York: Free press; 1991
  8. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al. Sertralin treatment for major depression with myocardial infarction or unstable angina. J Am Med Assoc 2002; 288: 701-9
  9. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785-9
  10. Lesperance F, Frasure-Smith N, Talajik M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996; 58: 99-110
  11. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: Final follow-up experience of 8.5 years. J Am Med Assoc 1975; 223: 872-7
  12. Sirois BC, Burg MM. Negative emotion and coronary heart disease. Behav Modif 2003: 27: 83-102
  13. Kubzansky LD, Kawachi I, Weiss ST, Sparrow D. Anxiety and coronary heart disease: A synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998; 20: 47-58
  14. Ketterer MW. Cognitive/behavioral therapy of anxiety in the medically ill: Cardiac settings. Semin Clin Neuropsychiatry 1999; 4: 148-53
  15. Jacqueline JMH, Johan D, Richel L, Adriaan H. Comparing symptoms of depression and anxi